(1)
Zaenglein, A.; Del Rosso, J. An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients With Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period. J of Skin 2018, 2, S33.